I'm still the person who packs an anti-nausea kit. Most sailings are smooth because I plan ahead. But earlier this year, crossing rough waters in ...
News-Medical.Net on MSN
New intramuscular mRNA vaccine offers easier alternative to treat neovascular eye diseases
An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...
ARS Pharmaceuticals' Neffy nasal spray showed 89.2% success in treating anaphylaxis in 545 patients, comparable to epinephrine injections. FDA approved Neffy in 2024 for adults and children over 30 kg ...
The “most dreaded” complication is fat embolism — a rare but life-threatening condition that strikes when fat enters the ...
A landscaper who is allergic to water has been forced to give up work because rain leaves him in excruciating pain. James ...
Initial $100 million term loan to propel market share growth in the U.S.SAN DIEGO, Sept (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc.
Chronic diseases are no joke. Anyone who has ever had to deal with long-lasting illnesses knows how much it impacts their ...
Air Force Technology on MSN
EU invest €30m in first private credit vehicle dedicated to defence
The European Investment Fund, the European Union's (EU) specialised financial institution for risk finance, is aiming to ...
The Zimbabwean on MSN
January disease has devastated cattle populations in Zimbabwe. How are farmers responding?
Since 2016, January disease (theileriosis) has decimated more than half a million cattle in many rural parts of Zimbabwe.
Megan Blain has been using sunbeds for almost four years and says she 'physically has to go on' them, despite the huge health ...
From the unproven medical claims to the self-proclaimed expertise, anyone watching Donald Trump's autism announcements Monday ...
Swiss pharmaceutical and diagnostics giant Roche Holding has finally released some positive news about its oral breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results